Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Benko

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|November 16, 2001
Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serumM S Kopreski, F A Benko, C D Gocke
Human Genetics|April 1, 1998
Transmission of mitochondrial DNA heteroplasmy in normal pedigreesC D Gocke, F A Benko, P K Rogan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Detection of tumor messenger RNA in the serum of patients with malignant melanomaM S Kopreski, F A Benko, L W Kwak, et al.
Annals of the New York Academy of Sciences|May 20, 2000
p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomasC D Gocke, F A Benko, M S Kopreski, et al.
Human Pathology|January 1, 1997
KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinomaC D Gocke, D J Dabbs, F A Benko, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Enrichment methods for mutation detectionC D Gocke, F A Benko, M S Kopreski, et al.
Leukemia & Lymphoma|September 7, 2000
Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease markerC D Gocke, M S Kopreski, F A Benko, et al.
Journal of the National Cancer Institute|June 8, 2000
Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNAM S Kopreski, F A Benko, D J Borys, et al.
British Journal of Cancer|January 1, 1997
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancerM S Kopreski, F A Benko, C Kwee, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1996
Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomasD A Belchis, C A Meece, F A Benko, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|November 16, 2001
Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serumM S Kopreski, F A Benko, C D Gocke
Human Genetics|April 1, 1998
Transmission of mitochondrial DNA heteroplasmy in normal pedigreesC D Gocke, F A Benko, P K Rogan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Detection of tumor messenger RNA in the serum of patients with malignant melanomaM S Kopreski, F A Benko, L W Kwak, et al.
Annals of the New York Academy of Sciences|May 20, 2000
p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomasC D Gocke, F A Benko, M S Kopreski, et al.
Human Pathology|January 1, 1997
KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinomaC D Gocke, D J Dabbs, F A Benko, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Enrichment methods for mutation detectionC D Gocke, F A Benko, M S Kopreski, et al.
Leukemia & Lymphoma|September 7, 2000
Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease markerC D Gocke, M S Kopreski, F A Benko, et al.
Journal of the National Cancer Institute|June 8, 2000
Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNAM S Kopreski, F A Benko, D J Borys, et al.
British Journal of Cancer|January 1, 1997
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancerM S Kopreski, F A Benko, C Kwee, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1996
Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomasD A Belchis, C A Meece, F A Benko, et al.
Pageof 2